Tokyo, May 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061623) titled 'Observational Study of HER2 Expression in Surgical Specimens of Gastric Cancer' on May 19.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka International Cancer Institute
Condition:
Condition - Gastric and Esophagogastric Junction Adenocarcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the impact of reducing the time required for specimen processing and increasing the number of pathological evaluation sections on HER2 diagnosis in surgical specimens of gastric cancer.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients scheduled to undergo gastrectomy for gastric cancer.
Histologically diagnosed adenocarcinoma (conventional type or lymphocyte-rich carcinoma).
Preoperatively diagnosed as cT2 or deeper according to the Japanese Classification of Gastric Carcinoma, 15th edition.
Age over 18 years at the time of enrollment.
Written informed consent for study participation has been obtained from the patient.
Key exclusion criteria - History of preoperative chemotherapy or radiotherapy for gastric cancer.
Patients deemed inappropriate for participation by the investigator.
Target Size - 180
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 09 Day
Date of IRB - 2025 Year 08 Month 03 Day
Anticipated trial start date - 2025 Year 08 Month 13 Day
Last follow-up date - 2033 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070503
Disclaimer: Curated by HT Syndication.
